|
611 |
Therapeutic Drug Monitoring of Imatinib Enthalten in Clinical pharmacokinetics Bd. 51, 30.9.2012, Nr. 3, date:3.2012: 187-201
|
|
|
612 |
Therapeutic Efficacy and Tolerability of the Topical Treatment of Inflammatory Conditions of the Oral Cavity with a Mouthwash Containing Diclofenac Epolamine Enthalten in Clinical drug investigation Bd. 32, 29.8.2012, Nr. 1, date:1.2012: 41-49
|
|
|
613 |
Therapeutic Switch to Buprenorphine/Naloxone from Buprenorphine Alone Enthalten in Clinical drug investigation Bd. 30, 17.9.2012, Nr. 1, date:4.2010: 13-19
|
|
|
614 |
Thorough QT Studies Enthalten in Drug safety Bd. 33, 19.10.2012, Nr. 1, date:1.2010: 1-14
|
|
|
615 |
Thrombocytopenia in Adult Cancer Patients Receiving Cytotoxic Chemotherapy Enthalten in Drug safety Bd. 34, 29.12.2012, Nr. 12, date:12.2011: 1151-1160
|
|
|
616 |
Time for Cooperation in Health Economics among the Modelling Community Enthalten in PharmacoEconomics Bd. 28, 29.9.2012, Nr. 8, date:8.2010: 609-613
|
|
|
617 |
Tissue-Selective Estrogen Complex Bazedoxifene and Conjugated Estrogens for the Treatment of Menopausal Vasomotor Symptoms Enthalten in Drugs Bd. 71, 24.9.2012, Nr. 13, date:9.2011: 1649-1657
|
|
|
618 |
Today’s Challenges in Pharmacovigilance Enthalten in Drug safety Bd. 34, 21.11.2012, Nr. 4, date:4.2011: 273-287
|
|
|
619 |
Topical Pimecrolimus 1% Cream for Resistant Seborrheic Dermatitis of the Face Enthalten in American journal of clinical dermatology Bd. 11, 10.9.2012, Nr. 1, date:2.2010: 51-54
|
|
|
620 |
Topical Treatment of Actinic Keratoses with Piroxicam 1% Gel Enthalten in American journal of clinical dermatology Bd. 11, 10.9.2012, Nr. 1, date:2.2010: 45-50
|
|